John Kurhanewicz, PhD, professor in residence and director of the UCSF Body Research Interest Group, the Biomedical NMR lab, and the Kurhanewicz Laboratory, is involved in cutting-edge research to more accurately and efficiently detect and characterize prostate cancers at early stages.
For Dr. Yee, virtual holography CT colonography (CTC) is the latest phase in a two-decade research career devoted to detecting colorectal cancer at earlier, more lifesaving stages.
Dr. Yee is a nationally recognized expert in CT colonography and, through her position as chair of the American College of Radiology’s Colon Cancer Committee, has fought on behalf of annual preventative colorectal cancer screening with insurance reimbursement for CT Colonography in patients age 50 and older.
Lisa Rooney, a member of the CT or CAT radiology team, works closely with patients during their kidney tumor ablation, among other procedures, ensuring safety and accuracy are maximized, while giving the patient the best possible experience.
Some patients with kidney tumors have a high risk of surgical complications because of their age or health status. For those patients, kidney tumor ablation offers a promising alternative to nephrectomy. Ablation is a nonsurgical procedure that is effective with small tumors.
Patients with kidney tumors sometimes have treatment options and at UCSF, an outcome-focused commitment across departments will often result in a combination of these approaches.
PET/MRI is a hybrid imaging technology that is serving critical diagnostic and treatment purposes for current UCSF patients as well as playing an important role in research for future patients.
PET/MRI provides high-quality images while reducing patient exposure to radiation. This combined technology is used for the diagnosis, staging and treatment of a variety of conditions, including cancer, neurological, oncological and musculoskeletal diseases.
